|
| CORRESPONDENCE |
|
|
|
| Year : 2009 | Volume
: 41
| Issue : 6 | Page : 289 |
| |
Authors' reply
Kavitha S Nair, Kirti V Patel, Tejal R Gandhi
Department of Pharmacology, Anand Pharmacy College, Opp. Town Hall, Anand-388001, Gujarat, India
| Date of Web Publication | 12-Feb-2010 |
Correspondence Address:
Kavitha S Nair
Department of Pharmacology, Anand Pharmacy College, Opp. Town Hall, Anand-388001, Gujarat
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0253-7613.59932
How to cite this article:
Nair KS, Patel KV, Gandhi TR. Authors' reply. Indian J Pharmacol 2009;41:289 |
Sir,
- It appears from the above discussion that the modulatory role of cytochromes on pioglitazone is doubtful, but numerous evidences has accumulated after the above-cited references that have supported the role of pioglitazone as cytochrome p450 enzyme inducer (although weak). [1],[2]
- The benefits of ANOVA and post hoc Tuckey can be considered to be equivalent to Chi-square test.
| » References | |  |
| 1. | Sahi J, Black CB, Hamilton GA, Zheng X, Jolley S, Rose KA, et al. Comparative effects of thiazolidinediones on In Vitro P450 enzyme Induction And Inhibition. Drug Metab Dispos 2003;31:439-46.  [PUBMED] [FULLTEXT] |
| 2. | Ripp SL, Mills JB, Fahmi OA, Trevena KA, Liras JL, Maurer TS, et al. Use of Immortalized Human Hepatocytes to Predict the Magnitude of Clinical Drug-Drug interactions caused by CYP3A4 induction. Drug Metab Dispos 2006;34:1742-8. [PUBMED] [FULLTEXT] |
|
